Device Ortho-Knee

Attune

Payments companies reported to CMS as associated with Attune. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$98Massociated payments (2023-2025)

1,781clinicians with associated payments

8companies reporting

By year

2023 $35M

2024 $31M

2025 $32M

Payments reported as associated with Attune, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $84M

Adult Reconstructive Orthopaedic Surgery $6.9M

Orthopaedic Trauma $131K

Surgery $56K

Sports Medicine (Orthopaedic Surgery) $25K

Colon & Rectal Surgery $15K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Attune

These are the largest totals companies reported as associated with Attune. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Daniel Berry	Rochester, MN	Orthopaedic Surgery	$8,421,420.61
Thomas Fehring	Charlotte, NC	Orthopaedic Surgery	$7,802,902.72
John Callaghan	Iowa City, IA	Orthopaedic Surgery	$7,208,722.30
Douglas Dennis	Denver, CO	Orthopaedic Surgery	$7,207,241.96
Robert Gorab	Orange, CA	Orthopaedic Surgery	$6,742,410.42
Robert Trousdale	Rochester, MN	Orthopaedic Surgery	$5,259,540.63
Thomas Thornhill	Boston, MA	Orthopaedic Surgery	$5,078,143.33
Chitranjan Ranawat	New York, NY		$4,881,305.29
Mark Pagnano	Rochester, MN	Orthopaedic Surgery	$4,578,981.93
Thomas Vail	Durham, NC	Orthopaedic Surgery	$2,557,205.77

Prescribed Attune?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.